0001144204-14-050192.txt : 20140814 0001144204-14-050192.hdr.sgml : 20140814 20140814161623 ACCESSION NUMBER: 0001144204-14-050192 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140630 FILED AS OF DATE: 20140814 DATE AS OF CHANGE: 20140814 EFFECTIVENESS DATE: 20140814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Knoll Capital Management, LP CENTRAL INDEX KEY: 0001325083 IRS NUMBER: 133476926 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11424 FILM NUMBER: 141043006 BUSINESS ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-808-7474 MAIL ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001325083 XXXXXXXX 06-30-2014 06-30-2014 false Knoll Capital Management, LP
5 East 44th Street 12th floor New York NY 10017
13F HOLDINGS REPORT 028-11424 N
Fred Knoll President 646-590-3960 /s/ Fred Knoll New York NY 08-14-2014 0 15 224399
INFORMATION TABLE 2 infotable.xml Newlink Genetics Corp Com 651511107 2056 77437 SH SOLE 77437 0 0 Medivation, Inc. Com 58501N101 175705 2279519 SH SOLE 2279519 0 0 Keryx Biopharmaceuticals Inc. Com 492515101 3076 200000 SH SOLE 200000 0 0 Echo Therapeutics Inc. Com New 27876L206 62 27430 SH SOLE 27430 0 0 Ampio Pharmaceuticals Inc. Com 03209T109 24753 2964401 SH SOLE 2964401 0 0 Alcobra Ltd SHS M2239P109 11892 687000 SH SOLE 687000 0 0 Inovio Pharmaceuticals Inc. COM NEW 45773H201 1109 102088 SH SOLE 102088 0 0 Advaxis Inc. COM NEW 7624208 709 225000 SH SOLE 225000 0 0 Advaxis Inc. W EXP 07/15/201 7624117 115 112500 SH SOLE 112500 0 0 Synthetic Biologics Inc. COM 87164U102 2394 1360000 SH SOLE 1360000 0 0 Northwest Biotherapeutics Inc COM PAR $0.001 66737P600 1344 200300 SH SOLE 200300 0 0 Nephrogenex Inc COMM 640667101 301 50000 SH SOLE 50000 0 0 Galmed Pharmaceuticals Ltd SHS M47238106 633 65000 SH SOLE 65000 0 0 Celsus Therapeutics Plc SPONSORED ADR NE 15119A202 78 14155 SH SOLE 14155 0 0 Provectus Biopharmaceuticals COM 74373P108 172 200000 SH SOLE 200000 0 0